Skip to main content
. 2020 May 22;158:104931. doi: 10.1016/j.phrs.2020.104931

Table 2.

Laboratory findings upon admission.

Median (IQR) or Number (%)
Parameter Total
(n = 233)
Survivors
(n = 185)
Non-survivors
(n = 48)
P
White blood cell count x 109/L 5.7 (4.4−7.5) 5.5 (4.4−7.1) 6.7 (4.8−9.0) 0.006
 >10 × 109/L 24 (10.3) 13 (7.0) 11 (22.9) 0.008
Lymphocyte count x 109/L 1.0 (0.7−1.3) 1.0 (0.8−1.4) 0.9 (0.6−1.1) 0.008
 <8.0 × 109/L 72 (30.9) 52 (28.1) 20 (41.7) 0.081
Neutrophil count x 109/L 4.1 (2.8−6.0) 3.9 (2.8−5.3) 5.7 (3.8−8.3) <0.001
Hemoglobin, g/dL 13.8 (12.6−14.8) 13.9 (13.0−14.8) 13.2 (11.7−14.3) 0.009
 Anemia* 111 (47.6) 79 (42.7) 32 (66.7) 0.003
Platelets x 109/L 176 (137−221) 174 (137−221) 181 (141−226) 0.534
Prothrombin, INR 1.2 (1.1−1.3) 1.2 (1.1−1.3) 1.2 (1.1−1.4) 0.188
Fibrinogen, g/L 7 (6.3−7) 7 (6−7) 7 (7−7) 0.148
D-dimer, μg/L 916 (535−1957) 808 (494−1480) 1740 (942−4851) <0.001
 <500 51 (21.9) 49 (26.5) 2 (4.2)
 500−1000 77 (33.0) 63 (34.1) 14 (29.2) 0.001
 > 1000 105 (45.1) 73 (39.5) 32 (66.7)
PaO2, mmHg 69.5 (61−80.7) 70.5 (62.7−81.2) 64.5 (57.2−76.5) 0.022
C-reactive protein, mg/L 47.6 (20.0−118.7) 40.9 (17.9−102.0) 130.0 (40.0−203.5) <0.001
 < 50 124 (53.2) 108 (58.4) 16 (33.3)
 50−100 33 (14.2) 28 (15.1) 5 (10.4) 0.001
 >100 76 (32.6) 49 (26.5) 27 (56.2)
Creatinine, mg/dL 0.96 (0.79−1.2) 0.93 (0.76−1.1) 1.1 (0.96−1.68) <0.001
Lactate dehydrogenase, U/L (n = 229) 338 (259−447) 305 (246−404) 438 (349−686) <0.001
Creatine kinase, U/L 109 (62.0−237.0) 93 (59.0−182.2) 251 (106.7−392.0) <0.001
 > 185 69 (29.6) 43 (23.2) 26 (54.2) <0.001
Alanine aminotransferase (U/L) 32 (20−53) 30 (20−49) 40 (28−59) 0.018
Bilirubin, mg/dL 1.2 (1.0−1.2) 1.2 (1.1−1.2) 1.1 (1.0−1.2) 0.509
Albumin, g/L (n = 222) 29 (25−33) 30 (26−34) 25 (23−30) <0.001

IQR = interquartile range; INR: International Normalised Ratio.

*

Anemia defined as a hemoglobin value of <12.5 g/dL for females and <14 g/dL for males.